These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3235056)

  • 1. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
    Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
    Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein abnormalities in non-insulin dependent diabetic patients with ischemic heart disease.
    Murakami T; Yamada N; Kawakubo K; Oku J; Mizushima Y; Iino S; Sugimoto T
    Artery; 1997; 22(4):206-32. PubMed ID: 9576026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary atherosclerosis and serum lipoproteins].
    Pometta D; Micheli H
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1926-30. PubMed ID: 231822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
    Karpe F; Steiner G; Olivecrona T; Carlson LA; Hamsten A
    J Clin Invest; 1993 Mar; 91(3):748-58. PubMed ID: 8450056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Oida K; Takeda R
    Artery; 1981; 9(6):477-93. PubMed ID: 6802107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein abnormalities in ischaemic heart disease.
    Lewis B; Carlson LA; Mancini M; Micheli H
    Postgrad Med J; 1975; 51(8):suppl 37-9. PubMed ID: 215980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
    Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
    Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of short term lipoprotein changes induced by single high cholesterol diet in healthy and diseases human volunteers.
    Arora RC; Agarwal N; Singh DK
    Mater Med Pol; 1991; 23(4):299-301. PubMed ID: 1842237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.
    Rivellese A; Riccardi G; Romano G; Giacco R; Patti L; Marotta G; Annuzzi G; Mancini M
    Diabetologia; 1988 Dec; 31(12):884-8. PubMed ID: 3240843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
    Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
    Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.